Merit Medical Systems EBITDA 2010-2024 | MMSI

Merit Medical Systems annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Merit Medical Systems EBITDA for the quarter ending March 31, 2024 was $0.064B, a 28.94% increase year-over-year.
  • Merit Medical Systems EBITDA for the twelve months ending March 31, 2024 was $0.241B, a 25.93% increase year-over-year.
  • Merit Medical Systems 2023 annual EBITDA was $0.227B, a 25.85% increase from 2022.
  • Merit Medical Systems 2022 annual EBITDA was $0.18B, a 14.67% increase from 2021.
  • Merit Medical Systems 2021 annual EBITDA was $0.157B, a 48.68% increase from 2020.
Merit Medical Systems Annual EBITDA
(Millions of US $)
2023 $227
2022 $180
2021 $157
2020 $106
2019 $120
2018 $129
2017 $87
2016 $79
2015 $76
2014 $77
2013 $61
2012 $52
2011 $52
2010 $32
2009 $45
Merit Medical Systems Quarterly EBITDA
(Millions of US $)
2024-03-31 $64
2023-12-31 $61
2023-09-30 $62
2023-06-30 $54
2023-03-31 $50
2022-12-31 $54
2022-09-30 $42
2022-06-30 $46
2022-03-31 $38
2021-12-31 $46
2021-09-30 $40
2021-06-30 $33
2021-03-31 $39
2020-12-31 $43
2020-09-30 $27
2020-06-30 $8
2020-03-31 $28
2019-12-31 $23
2019-09-30 $24
2019-06-30 $38
2019-03-31 $35
2018-12-31 $33
2018-09-30 $39
2018-06-30 $33
2018-03-31 $24
2017-12-31 $28
2017-09-30 $15
2017-06-30 $26
2017-03-31 $18
2016-12-31 $25
2016-09-30 $15
2016-06-30 $22
2016-03-31 $18
2015-12-31 $18
2015-09-30 $18
2015-06-30 $22
2015-03-31 $18
2014-12-31 $24
2014-09-30 $21
2014-06-30 $16
2014-03-31 $15
2013-12-31 $20
2013-09-30 $17
2013-06-30 $15
2013-03-31 $10
2012-12-31 $10
2012-09-30 $15
2012-06-30 $14
2012-03-31 $13
2011-12-31 $11
2011-09-30 $11
2011-06-30 $15
2011-03-31 $15
2010-12-31 $10
2010-09-30 $0
2010-06-30 $12
2010-03-31 $10
2009-12-31 $11
2009-09-30 $12
2009-06-30 $12
2009-03-31 $11
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $5.034B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.631B 21.23
Becton Dickinson (BDX) United States $67.642B 19.14
West Pharmaceutical Services (WST) United States $23.823B 42.69
Cardinal Health (CAH) United States $23.375B 13.37
Align Technology (ALGN) United States $18.864B 36.42
Labcorp (LH) United States $18.190B 15.66
Cooper (COO) United States $18.112B 26.71
Henry Schein (HSIC) United States $9.120B 16.22
DENTSPLY SIRONA (XRAY) United States $5.718B 14.81
Patterson (PDCO) United States $2.315B 11.42
CONMED (CNMD) United States $2.267B 20.56
STAAR Surgical (STAA) United States $2.173B 83.45
Atrion (ATRI) United States $0.803B 42.90
Lifevantage (LFVN) United States $0.081B 10.51
Pro-Dex (PDEX) United States $0.068B 34.31